Inventor · disambiguated record
Enrico Braglia
Also filed as: BRAGLIA ENRICO
4 granted patents·7 pending applications·47 citations·filing 2005–2011
78Inventor score
Files withHELSINN HEALTHCARE SA7BONADEO DANIELE1HELSINN ADVANCED SYNTHESIS SA1MACCIOCCHI ALBERTO1PERICLE FEDERICA1
Top patents by PatentIndex Score
11 records- 0192US7960424B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Granted Jun 14, 2011·16 cites·6 claims
- 0292US7947725B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Granted May 24, 2011·15 cites·2 claims
- 0392US7947724B2Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2005·Granted May 24, 2011·16 cites·14 claims
- 0466US2010105724A1Crystalline and amorphous forms of palonosetron hydrochlorideHELSINN HEALTHCARE SA·Filed 2007·Application pending·0 cites
- 0553US2006167072A1Liquid pharmaceutical formulations of palonosetronHELSINN HEALTHCARE SA·Filed 2006·Application pending·0 cites
- 0653US2008152704A1Dosage Forms of Palonosetron Hydrochloride Having Improved Stability and BioavailabilityBONADEO DANIELE·Filed 2007·Application pending·0 cites
- 0747US2006079545A1Palonosetron for the treatment of chemotherapy induced emesesHELSINN HEALTHCARE SA·Filed 2005·Application pending·0 cites
- 0846US2010256243A1Dosing Regimen for the Treatment of Alzheimer's Disease With Sulfonyl FluoridesPERICLE FEDERICA·Filed 2009·Application pending·0 cites
- 0942US2011178118A1Palonosetron for the treatment of chemotherapy induced emesesMACCIOCCHI ALBERTO·Filed 2011·Application pending·0 cites
- 1040US2006074101A1Method of treating post operative nausea and vomitingHELSINN HEALTHCARE SA·Filed 2005·Application pending·0 cites
- 1126US7057058B2Process for the preparation of 13-cis-retinoic acidHELSINN ADVANCED SYNTHESIS SA·Filed 2005·Granted Jun 6, 2006·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Enrico Braglia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →